This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy-related information (MSI and TMB), tumor core signaling pathway and tumor prognosis. The types of variants detected include SNV, InDel, amplifications and gene fusions, helping doctors formulate professional and individualized treatment plans for patients.